FNY Investment Advisers’s Novo Nordisk NVO Stock Holding History

FNY Investment Advisers’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$47K	Buy	1,250 +110	+10%	+$5.07K	0.01%	416
2026 Q2	$54K	Sell	1,140 -990	-46%	-$42.5K	0.02%	407
2026 Q1	$78K	Buy	2,130 +30	+1%	+$1.42K	0.03%	312
2025 Q4	$106K	Buy	+2,100	New	+$107K	0.03%	333
2025 Q2	–	Sell	-8,972	Closed	-$623K	–	1117
2025 Q1	$623K	Buy	+8,972	New	+$741K	0.38%	67
2023 Q4	–	Sell	-3,000	Closed	-$272K	–	704
2023 Q3	$272K	Buy	+3,000	New	+$264K	0.16%	88
2022 Q4	–	Sell	-80,000	Closed	-$3.98M	–	676
2022 Q3	$3.98M	Buy	+80,000	New	+$4.29M	2.76%	5
2021 Q1	–	Sell	-37,800	Closed	-$1.32M	–	951
2020 Q4	$1.32M	Buy	37,800 +1,200	+3%	+$41.5K	0.36%	65
2020 Q3	$1.27M	Buy	36,600 +24,000	+190%	+$800K	0.54%	51
2020 Q2	$412K	Buy	12,600 +2,600	+26%	+$83K	0.24%	96
2020 Q1	$301K	Buy	+10,000	New	+$298K	0.23%	88
2019 Q4	–	Sell	-10,000	Closed	-$258K	–	992
2019 Q3	$258K	Buy	+10,000	New	+$253K	0.08%	142

Other funds holding NVO

SRIM

Saratoga Research & Investment Management Saratoga, California $1.82B AUM 11.8% 1-Year Est. Return

EPAM

Euro Pacific Asset Management Dorado, Puerto Rico $1.22B AUM 22.48% 1-Year Est. Return

NPA

Nichols & Pratt Advisers Boston, Massachusetts $1.68B AUM 20.22% 1-Year Est. Return

GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return

CFIA

Cantor Fitzgerald Investment Advisors New York $1.47B AUM 20.15% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

VFM

Viking Fund Management Minot, North Dakota $1.14B AUM 32.65% 1-Year Est. Return

ERP

Eldred Rock Partners San Antonio, Texas $451M AUM 38.39% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return

BIAS

Beacon Investment Advisory Services Morristown, New Jersey $2.66B AUM 29.77% 1-Year Est. Return

FNY Investment Advisers's NVO Position: Q3 2026 in Review

FNY Investment Advisers increased its Novo Nordisk (NVO) stake by 9.6% in Q3 2026, buying an estimated $5.07K and bringing the position to 1,250 shares worth $47K. The position accounts for 0.01% of the portfolio, ranked #416.

FNY Investment Advisers first reported a position in NVO in Q3 2019 and has held it in 12 quarters since. The position peaked at $3.98M in Q3 2022. 182 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

FNY Investment Advisers held 1,250 shares of Novo Nordisk worth $47K as of Q3 2026.
FNY Investment Advisers bought 110 Novo Nordisk shares in Q3 2026, an estimated $5.07K.
Novo Nordisk made up 0.01% of FNY Investment Advisers's portfolio in Q3 2026, its #416 holding.
FNY Investment Advisers first reported a position in Novo Nordisk in Q3 2019 and has held it in 12 quarters since.
FNY Investment Advisers's Novo Nordisk position peaked at $3.98M in Q3 2022.
182 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on FNY Investment Advisers's 13F filing for Q3 2026, filed 16 Oct 2026.